z-logo
Premium
Oral contraceptive use in women at increased risk of breast/ovarian cancer: knowledge and attitudes
Author(s) -
Bui Kim Tam,
Wakefield Claire E.,
Kasparian Nadine A.,
Tyler Janet,
Abbott Jason,
Tucker Kathy
Publication year - 2013
Publication title -
psycho‐oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.41
H-Index - 137
eISSN - 1099-1611
pISSN - 1057-9249
DOI - 10.1002/pon.2049
Subject(s) - medicine , breast cancer , gynecology , ovarian cancer , obstetrics , cancer , oncology
Background Several of the health benefits and risks associated with the combined oral contraceptive pill (COCP) are particularly relevant to women at risk of hereditary breast and/or ovarian cancer. Methods Eighty‐three past female patients of an Australian hereditary cancer clinic aged 18–50 years completed a self‐report questionnaire to assess their contraceptive practices, knowledge and information needs (44% response rate). Results Ninety‐two percent of participants had previously used the COCP, with a mean knowledge score of 3.63 out of 8. Nearly 40% reported that their family history of cancer was one reason they discontinued/avoided using the COCP. Women reported receiving insufficient COCP information and preferred a targeted information leaflet to answer their questions. Conclusions Although recall bias may have affected some women, there is a clear need to improve the consistency of information delivered to women at risk of hereditary breast and/or ovarian cancer, to ensure informed contraceptive choices are made. Copyright © 2011 John Wiley & Sons, Ltd.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom